Mazdutide vs Survodutide: price and facts compared (2026)
Neither product has an in-stock offer right now.
| Mazdutide | Survodutide | |
|---|---|---|
| Category | GLP-1 | GLP-1 |
| Standard size | 10mg | 10mg |
| All sizes | 5mg, 10mg | 5mg, 10mg |
| Cheapest now | Not in stock | Not in stock |
| Price per mg | Priced as a set | Priced as a set |
| Vendors | 0 | 0 |
| Forms | Vial | Vial |
| Regulatory status | Investigational · phase 3 in China (Innovent / Eli Lilly). Not approved for human use. | Investigational · phase 3 (Boehringer Ingelheim / Zealand). Not approved for human use. |
| Stock | Out of stock | Out of stock |
Mazdutide is an investigational dual GLP-1 and glucagon receptor agonist developed by Innovent and Eli Lilly, in phase 3 obesity trials in China. Research vendors sell it lyophilized in 5 mg and 10 mg vials.
Mazdutide prices →Survodutide (BI 456906) is an investigational dual glucagon and GLP-1 receptor agonist developed by Boehringer Ingelheim and Zealand Pharma, in phase 3 obesity trials. It is sold lyophilized in 5 mg and 10 mg vials for research.
Survodutide prices →Questions
Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. Prices include a discount only when the offer shows a code, and exclude shipping. Stock status is captured at the same time. Rankings are by price only. PeptideTech earns a commission when you buy through a link; it never changes the order.
Full method →